BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cui J, Dong BW, Liang P, Yu XL, Yu DJ. Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma. World J Gastroenterol 2005; 11(20): 3027-3033 [PMID: 15918184 DOI: 10.3748/wjg.v11.i20.3027]
URL: https://www.wjgnet.com/1007-9327/full/v11/i20/3027.htm
Number Citing Articles
Mathieu Boissan, Marie-Lise Lacombe. Nm23/NDP kinases in hepatocellular carcinomaJournal of Bioenergetics and Biomembranes 2006; 38(3-4): 169 doi: 10.1007/s10863-006-9031-4
Zhengbin Zhang, Dylan Harris, Virendra N. Pandey. The FUSE Binding Protein Is a Cellular Factor Required for Efficient Replication of Hepatitis C VirusJournal of Virology 2008; 82(12): 5761 doi: 10.1128/JVI.00064-08
Zhao-Hui Sun, Wen-Li Ma, Bao Zhang, Yi-Fei Peng, Wen-Ling Zheng. Application of restriction display PCR technique in the preparation of cDNA microarray probesWorld Journal of Gastroenterology 2005; 11(48): 7579-7584 doi: 10.3748/wjg.v11.i48.7579
Rajeev Kaul, Masanao Murakami, Pankaj Kumar, Erle S. Robertson. Cancer Genome and Tumor Microenvironment2010; : 233 doi: 10.1007/978-1-4419-0711-0_11
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic reviewEuropean Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
Hanan H. Fouad, Ahmed B. Demery, Hussein M. Yehia, Reda M. El-Badawy. Molecular markers as a prognostic system for hepatocellular carcinomaJournal of Advanced Research 2011; 2(4): 333 doi: 10.1016/j.jare.2011.02.006
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrenceCritical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
Choon-Yee Tan, Christina L Chang. NDPKA is not just a metastasis suppressor – be aware of its metastasis-promoting role in neuroblastomaLaboratory Investigation 2018; 98(2): 219 doi: 10.1038/labinvest.2017.105
Smruti Mohanty, Donald Jensen. Hepatocellular Carcinoma2009; : 62 doi: 10.3109/9780203092880-6
Daniel H. Palmer, Philip J. Johnson. TNM Online2006;  doi: 10.1002/0471463736.tnmp20.pub2
Godfrey Grech, Xianquan Zhan, Byong Chul Yoo, Rostyslav Bubnov, Suzanne Hagan, Romano Danesi, Giorgio Vittadini, Dominic M Desiderio. EPMA position paper in cancer: current overview and future perspectivesEPMA Journal 2015; 6(1) doi: 10.1186/s13167-015-0030-6
Chengkun Yang, Chuangye Han, Xiangkun Wang, Xiwen Liao, Xiaoguang Liu, Wei Qin, Long Yu, Guangzhi Zhu, Hao Su, Sicong Lu, Zhiwei Chen, Tingdong Yu, Zhen Liu, Ketuan Huang, Zhengtao Liu, Yu Liang, Jianlu Huang, Tao Peng. Clinical Implication and the Hereditary Factors of NM23 in Hepatocellular Carcinoma Based on Bioinformatics Analysis and Genome–Wide Association StudyJournal of Oncology 2018; 2018: 1 doi: 10.1155/2018/6594169
Lohit Khera, Catherine Paul, Rajeev Kaul. Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1Virology 2017; 506: 110 doi: 10.1016/j.virol.2017.03.014
Ji-Dong Chen, Yan-Qun Xiong, Ke Dong, Jun Luo, Lin-Xian Yue, Qin Chen. Clinical Significance of Joint Detection of Serum VEGF, SIL-2R and HGF in Patients with Primary Hepatocellular Carcinoma before and after Percutaneous Microwave Coagulation TherapyAsian Pacific Journal of Cancer Prevention 2014; 15(11): 4545 doi: 10.7314/APJCP.2014.15.11.4545
Mohammed Asmal, Michael Seaman, Wenyu Lin, Raymond T Chung, Norman L Letvin, Ralf Geiben-Lynn. Inhibition of HCV by the serpin antithrombin IIIVirology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-226